A detailed history of Jpmorgan Chase & CO transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 162,784 shares of MEDP stock, worth $51.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
162,784
Previous 173,685 6.28%
Holding current value
$51.8 Million
Previous $70.2 Million 4.49%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$372.0 - $424.34 $4.06 Million - $4.63 Million
-10,901 Reduced 6.28%
162,784 $67 Million
Q1 2024

May 10, 2024

BUY
$284.87 - $413.31 $3.92 Million - $5.69 Million
13,767 Added 8.61%
173,685 $70.2 Million
Q4 2023

Feb 12, 2024

BUY
$227.52 - $312.68 $8.72 Million - $12 Million
38,334 Added 31.53%
159,918 $49 Million
Q3 2023

Nov 14, 2023

SELL
$233.98 - $281.67 $999,796 - $1.2 Million
-4,273 Reduced 3.4%
121,584 $29.4 Million
Q2 2023

Aug 11, 2023

BUY
$187.26 - $240.17 $2.81 Million - $3.6 Million
14,987 Added 13.52%
125,857 $30.2 Million
Q1 2023

May 18, 2023

BUY
$174.31 - $239.52 $10.9 Million - $15 Million
62,716 Added 130.24%
110,870 $20.8 Million
Q1 2023

May 11, 2023

SELL
$174.31 - $239.52 $9.1 Million - $12.5 Million
-52,198 Reduced 52.01%
48,154 $9.06 Million
Q4 2022

Feb 13, 2023

SELL
$153.06 - $226.57 $719,688 - $1.07 Million
-4,702 Reduced 4.48%
100,352 $21.3 Million
Q3 2022

Nov 14, 2022

SELL
$145.13 - $182.49 $737,260 - $927,049
-5,080 Reduced 4.61%
105,054 $16.5 Million
Q2 2022

Aug 11, 2022

SELL
$130.2 - $168.03 $999,154 - $1.29 Million
-7,674 Reduced 6.51%
110,134 $16.5 Million
Q1 2022

May 11, 2022

BUY
$138.87 - $214.31 $1.48 Million - $2.28 Million
10,632 Added 9.92%
117,808 $19.3 Million
Q4 2021

Feb 10, 2022

BUY
$182.74 - $227.9 $2.16 Million - $2.69 Million
11,808 Added 12.38%
107,176 $23.3 Million
Q3 2021

Nov 12, 2021

BUY
$170.18 - $198.21 $16.2 Million - $18.9 Million
95,368 New
95,368 $18.1 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $9.89B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.